Physical Therapists in Eastvale, CA Accepting Medicare
9 Physical Therapists found. Showing 1 - 9
 Anne Rojo, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 13163 Lavonda St, Eastvale, CA 92880 Phone: 951-278-9984 |
 Clement C Obinwanne Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 13049 Cheju Cir, Eastvale, CA 92880 Phone: 909-936-6542 |
Keyurkumar Patel Physical Therapist Medicare: Medicare Enrolled Practice Location: 6604 Bull Thistle Ct, Eastvale, CA 92880 Phone: 951-987-7008 |
Edgar Nepomuceno Malbas, P.T. Physical Therapist - Sports Medicare: Not Enrolled in Medicare Practice Location: 8721 Bald Eagle Dr, Eastvale, CA 92880 Phone: 949-836-2018 |
Ashish Nandkishore Bhambhani, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7056 Archibald St, Ste 102-353, Eastvale, CA 92880 Phone: 909-528-1449 Fax: 877-866-9299 |
Riteshkumar Gandhi Physical Therapist Medicare: Medicare Enrolled Practice Location: 6640 Bull Thistle Court, Eastvale, CA 92880 Phone: 248-497-6366 |
Samantha Stokes, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 14252 Schleisman Rd Ste 203, Eastvale, CA 92880 Phone: 951-460-0200 |
Karina Birung Gabriel, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 14335 Wisman Dr, Eastvale, CA 92880 Phone: 951-316-3850 |
 Body Basics Physical Therapy Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 14252 Schleisman Rd Ste 203, Eastvale, CA 92880 Phone: 951-273-7742 Fax: 951-273-7747 |
News Archive
X-spine launches three USFDA-cleared spinal implant systems
X-spine, a global leader in the design and manufacture of devices for the treatment of spinal disease, announces the market launch of three recently USFDA-cleared spinal implant systems. The systems are the IRIX-C cervical integrated interbody fusion system, the AXLE-X extended angle interspinous fixation system and the SILEX™ sacroiliac joint fusion system .
Lixte, NCI collaborate for clinical evaluation of LB-100 compound
Lixte Biotechnology Holdings announced today that the National Cancer Institute Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), National Institutes of Health (NIH), signed a NExT Material Transfer Agreement formalizing a collaboration with Lixte Biotechnology Holdings, Inc. for clinical evaluation of LB-100, one of Lixte's lead anti-cancer compounds.
Russia spent more than $80M in health-related foreign aid in 2010, report says
The Russian Federation in 2010 spent more than $80 million to improve health in developing countries, according to a report prepared by the country's Ministry of Finance, which highlights "how the country is meeting its G8 commitments ahead of the upcoming summit in Deauville, France," the Moscow Times reports.
Breast cancer survivors with excess body weight at increased risk of developing second cancer
Breast cancer survivors who are overweight have a statistically significant increased risk of developing second primary cancers, according to results from a study conducted by Kaiser Permanente researchers and published in the Journal of the National Cancer Institute.
› Verified 9 days ago
Optometrists
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Chiropractors